Helium

CHEMBL1796997 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
4.0 g/mol
LogP
Phase
4

A lightweight medical gas used as a diluent with oxygen to reduce the work of breathing in patients with severe airway obstruction.

Peso molecular

4,0026 g/mol

TPSA

0,00 Ų

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[He]

InChI

InChI=1S/He

Molecular Formula

He

HBD / HBA

- / -

Enlaces Rotables

0

Átomos Pesados

1

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

A lightweight medical gas used as a diluent with oxygen to reduce the work of breathing in patients with severe airway obstruction.

Yes, Helium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1796997. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23987. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.